Episode 96: The Story Behind Ventilator-associated Pneumonia
We know that ventilator-associated pneumonia (VAP) is a lethal hospital-acquired condition. The evidence is clear- VAP increases time on the ventilator, time in the ICU, time in the hospital, mortality, as well as healthcare costs. On average, 1 VAP increases costs by $45,609.
So why aren’t hospital systems panicked about VAPs?
When reported cases of VAP drastically decreased from 2005 to 2013, was that because practices improved, or did the reporting change?
What is going on with VAPs during COVID and why is the diagnosis and reporting of VAPs inconsistent and unreliable?
Dr. Benjamin Wang, the creator of NEVAP ASSETT, shares with us the real story behind ventilator-associated pneumonia in the USA.